Results 171 to 180 of about 605,155 (296)

Radiotherapy and Cancer [PDF]

Postgraduate Medical Journal, 1946
openaire   +4 more sources

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC). [PDF]

BMJ Open
Kagenaar E, Lugo-Palacios DG, Hutchings A, Aggarwal A, O'Neill S, Rachet B, Edwards J, Faivre-Finn C, Grieve R, Surgery or Radiotherapy Study (SORT) group.   +9 more
europepmc   +1 more source

Growth impairment following radiotherapy in childhood [PDF]

, 1968
W.B. Dawson
openalex   +1 more source

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source

Urinary Metabolites as Biomarkers of Early Radiation Cystitis in Patients With Prostate Cancer Undergoing Radiotherapy. [PDF]

In Vivo
Shiraishi S, Sugimoto M, Tokuuye K.
europepmc   +1 more source

Radiotherapy in the treatment of sarcomas of the corpus uteri [PDF]

, 1969
Ahmed O. Badib, Vitune Vongtama, Samuel S. Kurohara, John H. Webster   +3 more
openalex   +1 more source

Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors

Molecular Oncology, EarlyView.
Inhibition of protein SUMOylation has been shown to block tumorigenesis; however, the specific mechanisms by which SUMOylation controls the tumor‐initiating capacities remain elusive. Li et al. describe the role of Etv1 SUMOylation in cancer stem cells using mouse models of mammary gland tumorigenesis.
Veronika Yevdokimova, Yannick D. Benoit
wiley   +1 more source

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?

Chinese Journal of Cancer, 2017
Alexis Vallard, Chloé Rancoule, Jean-Baptiste Guy, Avi Assouline, Alexander T. Falk, Pierre Auberdiac, Julien Langrand-Escure, Cyrus Chargari, Nicolas Magné   +8 more
doaj   +1 more source

Robo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors. [PDF]

J Transl Med
Wu M, He J, Geng J, Wei Z, Cheng R, Li H, Xing L.   +6 more
europepmc   +1 more source